NAPRIX D 5 MG + 12,5 MG CAP DURA CT FR PLAS PEAD OPC X 10
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1003301780064 -
GGREM
523724060053203 -
Código de barras
7896094212558
O que a fonte publica
- Detentor do registro
- LIBBS FARMACÊUTICA LTDA
- Princípios ativos
- HIDROCLOROTIAZIDA;RAMIPRIL
- Embalagem
- 5 MG + 12,5 MG CAP DURA CT FR PLAS PEAD OPC X 10
- Regime de dispensação
- Tarja Vermelha sob restrição
- Tipo de produto
- Novo
- Classe terapêutica
- C9B1 - INIBIDORES DA ECA ASSOCIADOS A ANTI-HIPERTERSIVOS (C2) E/OU DIURÉTICOS (C3)
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "NAPRIX D 5 MG + 12,5 MG CAP DURA CT FR PLAS PEAD OPC X 10",
"holder": "LIBBS FARMACÊUTICA LTDA",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"7896094212558"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "523724060053203",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.230.314/0001-75",
"priceRegime": "Regulado",
"productName": "NAPRIX D",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "5 MG + 12,5 MG CAP DURA CT FR PLAS PEAD OPC X 10",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "15.68",
"icms-12": "17.82",
"icms-17": "18.89",
"icms-18": "19.12",
"icms-19": "19.36",
"icms-20": "19.60",
"icms-21": "19.85",
"icms-22": "20.10",
"icms-23": "20.36",
"icms-17.5": "19.01",
"icms-19.5": "19.48",
"icms-20.5": "19.72",
"icms-22.5": "20.23",
"icms-12-alc": "17.60",
"icms-17-alc": "18.66",
"icms-18-alc": "18.89",
"icms-19-alc": "19.13",
"icms-20-alc": "19.36",
"icms-21-alc": "19.61",
"icms-22-alc": "19.86",
"icms-23-alc": "20.12",
"withoutTaxes": "15.49",
"icms-17.5-alc": "18.78",
"icms-19.5-alc": "19.24",
"icms-20.5-alc": "19.49",
"icms-22.5-alc": "19.99"
},
"pisCofinsList": "Positiva",
"substanceText": "HIDROCLOROTIAZIDA;RAMIPRIL",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "21.61",
"icms-12": "24.56",
"icms-17": "26.04",
"icms-18": "26.35",
"icms-19": "26.69",
"icms-20": "27.02",
"icms-21": "27.36",
"icms-22": "27.71",
"icms-23": "28.06",
"icms-17.5": "26.20",
"icms-19.5": "26.85",
"icms-20.5": "27.18",
"icms-22.5": "27.88",
"icms-12-alc": "24.33",
"icms-17-alc": "25.80",
"icms-18-alc": "26.11",
"icms-19-alc": "26.45",
"icms-20-alc": "26.76",
"icms-21-alc": "27.11",
"icms-22-alc": "27.46",
"icms-23-alc": "27.81",
"withoutTaxes": "21.42",
"icms-17.5-alc": "25.96",
"icms-19.5-alc": "26.60",
"icms-20.5-alc": "26.94",
"icms-22.5-alc": "27.64"
},
"invalidBarcodes": [],
"activeSubstances": [
"HIDROCLOROTIAZIDA",
"RAMIPRIL"
],
"therapeuticClass": "C9B1 - INIBIDORES DA ECA ASSOCIADOS A ANTI-HIPERTERSIVOS (C2) E/OU DIURÉTICOS (C3)",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1003301780064",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "C9B1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:523724060053203"